LncRNA loc285194 is a p53-regulated tumor suppressor

被引:345
|
作者
Liu, Qian [1 ,2 ]
Huang, Jianguo [1 ,3 ]
Zhou, Nanjiang [1 ,3 ]
Zhang, Ziqiang [3 ]
Zhang, Ali [1 ]
Lu, Zhaohui [4 ]
Wu, Fangting [5 ]
Mo, Yin-Yuan [1 ,3 ]
机构
[1] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL USA
[2] Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China
[3] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA
[4] Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing 100853, Peoples R China
[5] Syst Biosci, Mountain View, CA USA
基金
美国国家卫生研究院;
关键词
LONG NONCODING RNA; HOST GENE; MICRORNA; CHROMATIN; ACTIVATION; CANCER; TRANSCRIPTION; EXPRESSION; PTEN; HULC;
D O I
10.1093/nar/gkt182
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein-coding genes account for only a small part of the human genome, whereas the vast majority of transcripts make up the non-coding RNAs including long non-coding RNAs (lncRNAs). Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis. LncRNA loc285194 was previously shown to be within a tumor suppressor unit in osteosarcoma and to suppress tumor cell growth. However, it is unknown regarding the regulation of loc285194. Moreover, the underlying mechanism by which loc285194 functions as a potential tumor suppressor is elusive. In this study, we show that loc285194 is a p53 transcription target; ectopic expression of loc285194 inhibits tumor cell growth both in vitro and in vivo. Through deletion analysis, we identify an active region responsible for tumor cell growth inhibition within exon 4, which harbors two miR-211 binding sites. Importantly, this loc285194-mediated growth inhibition is in part due to specific suppression of miR-211. We further demonstrate a reciprocal repression between loc285194 and miR-211; in contrast to loc285194, miR-211 promotes cell growth. Finally, we detect downregulation of loc285194 in colon cancer specimens by quantitative PCR arrays and in situ hybridization of tissue microarrays. Together, these results suggest that loc285194 is a p53-regulated tumor suppressor, which acts in part through repression of miR-211.
引用
收藏
页码:4976 / 4987
页数:12
相关论文
共 50 条
  • [41] Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD
    Budanov, AV
    Sablina, AA
    Feinstein, E
    Koonin, EV
    Chumakov, PM
    SCIENCE, 2004, 304 (5670) : 596 - 600
  • [42] Thymidine dinucleotide mimics the effect of solar simulated irradiation on p53 and p53-regulated proteins
    Goukassian, DA
    Eller, MS
    Yaar, M
    Gilchrest, BA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (01) : 25 - 31
  • [43] P53-regulated autophagy and its impact on drug resistance and cell fate
    Shim, Daeun
    Duan, Lei
    Maki, Carl G.
    CANCER DRUG RESISTANCE, 2021, 4 (01) : 85 - 95
  • [44] Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
    Zhao, RB
    Gish, K
    Murphy, M
    Yin, YX
    Notterman, D
    Hoffman, WH
    Tom, E
    Mack, DH
    Levine, AJ
    GENES & DEVELOPMENT, 2000, 14 (08) : 981 - 993
  • [45] YPEL3, a p53-Regulated Gene that Induces Cellular Senescence
    Kelley, Kevin D.
    Miller, Kelly R.
    Todd, Amber
    Kelley, Amy R.
    Tuttle, Rebecca
    Berberich, Steven J.
    CANCER RESEARCH, 2010, 70 (09) : 3566 - 3575
  • [46] Age-related dysfunction of p53-regulated phagocytic activity in macrophages
    Yamaguchi, Yohko
    Kaida, Kohei
    Suenaga, Yusuke
    Ishigami, Akihito
    Kobayashi, Yoshiro
    Nagata, Kisaburo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 529 (02) : 462 - 466
  • [47] THE P53-REGULATED INHIBITOR OF CDKS (PIC1) IS EXPRESSED AND REGULATED IN P53-DEFICIENT HUMAN LEUKEMIC-CELLS
    SCHWALLER, J
    KOEFFLER, HP
    NIKLAUS, G
    LOTSCHER, P
    NAGEL, S
    FEY, MF
    TOBLER, A
    BLOOD, 1994, 84 (10) : A21 - A21
  • [48] Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription
    K Kim
    K W Jeong
    H Kim
    J Choi
    W Lu
    M R Stallcup
    W An
    Oncogene, 2012, 31 : 4290 - 4301
  • [49] Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas
    Li, Lili
    Xu, Juan
    Qiu, Guohua
    Ying, Jianming
    Du, Zhenfang
    Xiang, Tingxiu
    Wong, Kai Yau
    Srivastava, Gopesh
    Zhu, Xiao-Feng
    Mok, Tony S.
    Chan, Anthony T. C.
    Chan, Francis K. L.
    Ambinder, Richard F.
    Tao, Qian
    THERANOSTICS, 2018, 8 (01): : 61 - 77
  • [50] p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint
    Yamaguchi, T
    Matsuda, K
    Sagiya, Y
    Iwadate, M
    Fujino, MA
    Nakamura, Y
    Arakawa, H
    CANCER RESEARCH, 2001, 61 (22) : 8256 - 8262